Clinical Trial

European Myeloma Network (EMN) Sample Project

Study acronym: EMN36
Recruiting
View on ClinicalTrials.gov →
Summary
This is an observational, non-interventional, multicenter study for the prospective collection, storage and analysis of patients' biological samples. This study establishes a common international infrastructure useful to collect standard clinical variables at baseline and during treatment and to uniformly collect and store biological samples
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-01-25; most recent amendment 2025-12-02.
Trial Details
NCT Number NCT06237803
Lead Sponsor European Myeloma Network B.V.
Collaborators: Janssen, LP
Conditions Multiple Myeloma, Smoldering Multiple Myeloma, Plasma Cell Leukemia, Extramedullary Myeloma, MGUS
Enrollment 6,000 participants
Start Date 2022-12-21
Primary Completion 2037-12 (estimated)
Study Completion 2037-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-03